GADA testing: the current state of knowledge

H Davies; S Brophy; S C Bain; J W Stephens; J Lewis; S Luzio; G Dunseath; C Beaverstock; D R R Williams

doi:10.1016/j.pcd.2009.07.002

GADA testing: the current state of knowledge

Prim Care Diabetes. 2009 Aug;3(3):189-91. doi: 10.1016/j.pcd.2009.07.002. Epub 2009 Aug 27.

Authors

H Davies¹, S Brophy, S C Bain, J W Stephens, J Lewis, S Luzio, G Dunseath, C Beaverstock, D R R Williams

Affiliation

¹ Centre for Health Information, Research and Evaluation [CHIRAL], The School of Medicine, Swansea University, Singleton Park, Swansea SA2 8PP, United Kingdom. h.davies@swansea.ac.uk

PMID: 19716357
DOI: 10.1016/j.pcd.2009.07.002

Abstract

This review considers the current knowledge and practice of GADA testing people with diabetes in Europe and the UK. Important issues are raised, including interpretation of the results and the clinical relevance of the GADA titre. Recommendations are made towards standardising GADA testing, using World Health Organization units.

Publication types

Review

MeSH terms

Biomarkers / blood
Diabetes Mellitus / blood
Diabetes Mellitus / classification
Diabetes Mellitus / enzymology*
Glutamate Decarboxylase / blood*
Humans
Hypoglycemic Agents / therapeutic use
Insulin / therapeutic use
Sensitivity and Specificity

Substances

Biomarkers
Hypoglycemic Agents
Insulin
Glutamate Decarboxylase